VistaGen Therapeutics, Inc. (VSTA) Seeks to Bring Human Biology to Front End of Drug Development Process
In the late 1990s, VistaGen Therapeutics’ founders established the company to make their dreams a reality. The founders wanted to create human cell-based biological assay systems that provide reliable insight into the healing and harmful effects of new drug candidates long before they are ever tested in humans and, now, next-generation biological assays can provide the type and quality of valuable pre-clinical human data that will increase the possibility of choosing safer, more effective therapeutics for clinical development. VistaGen's drug rescue pursuits combine its human pluripotent stem cell technology platform, Human Clinical Trials in a Test Tube™, with contemporary curative…